| scholarly article | Q13442814 |
| P356 | DOI | 10.4061/2011/262847 |
| P953 | full work available online at | http://downloads.hindawi.com/journals/ad/2011/262847.pdf |
| http://downloads.hindawi.com/journals/ad/2011/262847.xml | ||
| https://downloads.hindawi.com/journals/ad/2011/262847.pdf | ||
| https://europepmc.org/articles/PMC3038418 | ||
| https://europepmc.org/articles/PMC3038418?pdf=render | ||
| P932 | PMC publication ID | 3038418 |
| P698 | PubMed publication ID | 21331147 |
| P5875 | ResearchGate publication ID | 49845498 |
| P50 | author | Graham R Campbell | Q57017440 |
| P2093 | author name string | Don J. Mahad | |
| P2860 | cites work | Brain Pathology | Q4955776 |
| Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells | Q24291591 | ||
| Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis | Q24294447 | ||
| Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis | Q24338169 | ||
| The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease | Q24676476 | ||
| Mitochondrial DNA mutations in human disease | Q24676881 | ||
| Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial. | Q39858360 | ||
| A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. | Q40240586 | ||
| Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives | Q40895456 | ||
| Retrograde but not anterograde bead movement in intact axons requires dynein | Q41666684 | ||
| Axonal transport of mitochondria along microtubules and F-actin in living vertebrate neurons | Q41903637 | ||
| Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of Ranvier | Q43601410 | ||
| Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction | Q44285188 | ||
| Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration | Q44296099 | ||
| Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo | Q44540512 | ||
| Enhanced number and activity of mitochondria in multiple sclerosis lesions | Q44595788 | ||
| Axonal protection using flecainide in experimental autoimmune encephalomyelitis. | Q44880213 | ||
| Axonal mitochondrial transport and potential are correlated | Q44901240 | ||
| Sodium channels contribute to microglia/macrophage activation and function in EAE and MS. | Q45076768 | ||
| Gene expression analysis of normal appearing brain tissue in an animal model for multiple sclerosis revealed grey matter alterations, but only minor white matter changes | Q45203854 | ||
| Heterogeneous distribution of axonal cytoskeleton proteins in the human optic nerve | Q46147673 | ||
| Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients | Q47660422 | ||
| Co-localization of sodium channel Nav1.6 and the sodium-calcium exchanger at sites of axonal injury in the spinal cord in EAE. | Q48122449 | ||
| Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration | Q48232676 | ||
| Sodium channel Na(v)1.6 is expressed along nonmyelinated axons and it contributes to conduction | Q48460269 | ||
| Galactocerebroside antiserum causes demyelination of cat optic nerve | Q48506416 | ||
| The distribution of mitochondrial activity in relation to optic nerve structure | Q48587524 | ||
| Na(+)-Ca2+ exchanger mediates Ca2+ influx during anoxia in mammalian central nervous system white matter | Q48658234 | ||
| Amyloid precursor protein accumulates in white matter at the margin of a focal ischaemic lesion | Q48682199 | ||
| Cortical demyelination and diffuse white matter injury in multiple sclerosis. | Q48726181 | ||
| Axonal damage in acute multiple sclerosis lesions | Q48776354 | ||
| Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger | Q51697656 | ||
| Sodium channels in single demyelinated mammalian axons | Q51755545 | ||
| Mitochondrial Protein Nitration Primes Neurodegeneration in Experimental Autoimmune Encephalomyelitis | Q58119404 | ||
| Effect of Demyelination on Conduction in the Central Nervous System | Q59065519 | ||
| Axonal injury in multiple sclerosis | Q61709639 | ||
| Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells | Q67531806 | ||
| Nanomolar concentrations of nitric oxide reversibly inhibit synaptosomal respiration by competing with oxygen at cytochrome oxidase | Q72370715 | ||
| Beta-amyloid precursor protein (beta APP) as a marker for axonal injury after head injury | Q72624827 | ||
| The regulation of bidirectional mitochondrial transport is coordinated with axonal outgrowth | Q72789184 | ||
| Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis | Q74297187 | ||
| Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve | Q77094754 | ||
| Axonal protection achieved in a model of multiple sclerosis using lamotrigine | Q79547534 | ||
| Opa1 deficiency in a mouse model of autosomal dominant optic atrophy impairs mitochondrial morphology, optic nerve structure and visual function | Q80146686 | ||
| Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine | Q80678677 | ||
| Axonal dysfunction in chronic multiple sclerosis: meltdown in the membrane | Q80897644 | ||
| Distribution of mitochondria along small-diameter myelinated central nervous system axons | Q80995993 | ||
| Increase in mitochondrial density within axons and supporting cells in response to demyelination in the Plp1 mouse model | Q82002626 | ||
| Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse | Q82920303 | ||
| Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy | Q28140286 | ||
| Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta | Q28199148 | ||
| Multiple sclerosis | Q28299151 | ||
| Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis | Q28574796 | ||
| Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development | Q28594513 | ||
| Mitochondrial respiratory-chain diseases | Q29614474 | ||
| Axonal Transection in the Lesions of Multiple Sclerosis | Q29615585 | ||
| Kinesin-1 and Dynein are the primary motors for fast transport of mitochondria in Drosophila motor axons | Q30477062 | ||
| Low density of sodium channels supports action potential conduction in axons of neonatal rat optic nerve | Q33838989 | ||
| Sodium channel expression within chronic multiple sclerosis plaques | Q34680249 | ||
| Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. | Q34710256 | ||
| Imaging correlates of decreased axonal Na+/K+ ATPase in chronic multiple sclerosis lesions. | Q34774294 | ||
| Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease | Q35057231 | ||
| The role of nitric oxide in multiple sclerosis | Q35172450 | ||
| Traumatically induced axonal injury: pathogenesis and pathobiological implications | Q35243746 | ||
| The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head | Q35591713 | ||
| The diagnosis of mitochondrial muscle disease. | Q35690669 | ||
| Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis | Q35745786 | ||
| Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content | Q35894389 | ||
| Evolution of a neuroprotective function of central nervous system myelin | Q36117106 | ||
| In situ localization of mitochondrial DNA replication in intact mammalian cells | Q36256880 | ||
| Axon degeneration mechanisms: commonality amid diversity | Q36285969 | ||
| Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation | Q36484737 | ||
| Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. | Q36501983 | ||
| Axonal conduction and injury in multiple sclerosis: the role of sodium channels | Q36657811 | ||
| Mitochondrial changes within axons in multiple sclerosis | Q36709397 | ||
| Mitochondrial biogenesis in the axons of vertebrate peripheral neurons | Q36883274 | ||
| Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS | Q36897642 | ||
| Mechanisms of disease: sodium channels and neuroprotection in multiple sclerosis-current status | Q37070221 | ||
| Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis | Q37398059 | ||
| Overexpression of mitochondrial Hsp70/Hsp75 protects astrocytes against ischemic injury in vitro. | Q38786382 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | mitochondrion | Q39572 |
| P304 | page(s) | 262847 | |
| P577 | publication date | 2011-02-08 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Autoimmune Diseases | Q26842451 |
| P1476 | title | Mitochondria as crucial players in demyelinated axons: lessons from neuropathology and experimental demyelination | |
| Mitochondria as Crucial Players in Demyelinated Axons: Lessons from Neuropathology and Experimental Demyelination | |||
| P478 | volume | 2011 |
| Q33689103 | Aging-related changes of optic nerve of Wistar albino rats |
| Q91642009 | Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options |
| Q35856138 | Cell type-specific Nrf2 expression in multiple sclerosis lesions. |
| Q36570149 | Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression |
| Q53410201 | Combined effects of rat Schwann cells and 17β-estradiol in a spinal cord injury model. |
| Q92369012 | Distinctive functional deficiencies in axonal conduction associated with two forms of cerebral white matter injury |
| Q34831961 | Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis? |
| Q49161838 | Newly lesioned tissue in multiple sclerosis--a role for oxidative damage? |
| Q35910495 | Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination |
| Q41886918 | Paradigms in multiple sclerosis: time for a change, time for a unifying concept |
| Q46290321 | Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis |
Search more.